Biotech news
Americas
The US Food and Drug Administration has recommended that an application by pharmaceutical company Novartis to market a biosimilar version of Amgen’s cancer drug Neupogen (filgrastim) be approved. 5 January 2015
Americas
Law firm Fitzpatrick, Cella, Harper, & Scinto will begin the New Year with three new faces in its partnership. 19 December 2014
Americas
A US biotechnology company that was on the winning side of an EU court ruling surrounding the patentability of certain organisms has said it “clears the way” for patents in Europe. 19 December 2014
Americas
The US Patent and Trademark Office has issued new guidance for determining what claims are eligible for patenting, with one lawyer saying it could “muddy the waters”. 17 December 2014
Americas
Novartis’s generic arm Sandoz has failed to win a patent case regarding its biosimilar version of Amgen’s psoriasis and arthritis drug Enbrel (etanercept). 9 December 2014
Pharma
At first glance, it might seem odd for a company to both divide blood plasma and fight the side-effects of cancer treatment. But not for PlasmaTech Biopharmaceuticals, which tells LSIPR about how the company does it and also protects its IP. 26 November 2014
Biotech
The US Court of Appeals for the Federal Circuit has denied pharmaceutical company Antares Pharma an injunction that aimed to block a rival from allegedly infringing a patent covering injection devices. 18 November 2014
Americas
Healthcare company PDL BioPharma has announced that it will soon gain royalties from sales of Sanofi’s Cerdelga (eliglustat) drug, used to treat Gaucher disease. 11 November 2014
Biotech
Law firm Eversheds has expanded its IP practice in Belgium with the addition of a new life sciences partner. 6 November 2014
Americas
US-based law firm Ropes & Gray has promoted two to partner roles in its life science practice in New York. 4 November 2014